SCHEMBL750059

SCHEMBL750059

O=CC(Br)c1ccc2c(c1)oc1cc(Br)ccc12

nearest known ligand 0.36

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 2/20 0.36
CYP11B1 P15538 1/20 0.33
CYP11B2 P19099 1/20 0.33
BCHE P06276 4/20 0.33
ACHE P22303 4/20 0.33
PTPN1 P18031 1/20 0.33
LMNA P02545 2/20 0.32
MAPT P10636 2/20 0.32
KDM4E B2RXH2 1/20 0.32
ALDH1A1 P00352 1/20 0.32
ALOX15 P16050 1/20 0.32
HTT P42858 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
HSD17B10 Q99714 1/20 0.32
PIM1 P11309 1/20 0.32
PKM P14618 1/20 0.32
ERN1 O75460 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29654967 0.76 MAPT (0.50) CYP2A6CYP11B1CYP11B2LMNAMAPT
SCHEMBL203439 0.76 MAPT (0.50) CYP2A6CYP11B1CYP11B2LMNAMAPT
SCHEMBL20033064 0.76 LMNA (0.40) CYP11B1CYP11B2BCHEACHELMNA
SCHEMBL6989681 0.74 MAPT (0.46) LMNAMAPTKDM4EALDH1A1SMN1; SMN2
SCHEMBL524745 0.74 CYP2A6 (0.43) CYP2A6CYP11B1CYP11B2LMNAMAPT
SCHEMBL13242796 0.73 ALDH1A1 (0.47) CYP2A6CYP11B1CYP11B2PTPN1LMNA
SCHEMBL22590138 0.72 CYP2A6 (0.40) CYP2A6ALDH1A1ALOX15SMN1; SMN2
SCHEMBL321965 0.72 CYP2A6 (0.40) CYP2A6ALDH1A1ALOX15SMN1; SMN2
SCHEMBL21495049 0.70 ALDH1A1 (0.47) ALDH1A1
SCHEMBL540882 0.70 ALDH1A1 (0.47) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2430014-A1 ANTIVIRAL COMPOUNDS Gilead Sciences, Inc. (US) 2012-03-21 EP disclosed
WO-2010132601-A1 ANTIVIRAL COMPOUNDS GILEAD SCIENCES, INC. (US) 2010-11-18 WO disclosed